Eledon Pharmaceuticals (ELDN) Free Cash Flow (2016 - 2017)
Historic Free Cash Flow for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q3 2017 value amounting to -$3.4 million.
- Eledon Pharmaceuticals' Free Cash Flow fell 13072.25% to -$3.4 million in Q3 2017 from the same period last year, while for Sep 2017 it was -$13.6 million, marking a year-over-year decrease of 677.08%. This contributed to the annual value of -$47.3 million for FY2024, which is 1959.17% down from last year.
- As of Q3 2017, Eledon Pharmaceuticals' Free Cash Flow stood at -$3.4 million, which was down 13072.25% from -$8.0 million recorded in Q2 2017.
- In the past 5 years, Eledon Pharmaceuticals' Free Cash Flow registered a high of $7.6 million during Q2 2016, and its lowest value of -$11.2 million during Q2 2015.
- In the last 5 years, Eledon Pharmaceuticals' Free Cash Flow had a median value of -$5.9 million in 2014 and averaged -$5.4 million.
- As far as peak fluctuations go, Eledon Pharmaceuticals' Free Cash Flow soared by 16801.47% in 2016, and later plummeted by 20588.0% in 2017.
- Over the past 5 years, Eledon Pharmaceuticals' Free Cash Flow (Quarter) stood at -$6.8 million in 2013, then rose by 5.35% to -$6.5 million in 2014, then tumbled by 40.76% to -$9.1 million in 2015, then soared by 85.93% to -$1.3 million in 2016, then plummeted by 167.16% to -$3.4 million in 2017.
- Its last three reported values are -$3.4 million in Q3 2017, -$8.0 million for Q2 2017, and -$882000.0 during Q1 2017.